APEX1 and breast cancer: The APE1 low-level expression group was defined as breast cancer paraffin sections with <50% of tumor cells with positive immunostaining (Figure 1 B), and the APE1 high-level expression group was defined as those with ≥50% of tumor cells with positive immunostaining (Figure 1 C), which we have used in previous studies.